Skip to main content
Premium Trial:

Request an Annual Quote

Mark Modzelewski, President Bush, Henry Cisneros, Dan Glickman, Curtis Van Tassell, Ben Bronstein, Peter Johnson, Mark Braughler, Todd Joron, Max Fedor


Mark Modzelewski joins the scientific advisory board of CombiMatrix, the company said this week. Modzelewski is the founder and executive director of the Nanobusiness Alliance and is a member of the Nanotechnology Technical Advisory Group of President Bush’s Council of Advisors on Science and Technology. Previously, Modzelewski served as special assistant to HUD secretary Henry Cisneros and USDA secretary Dan Glickman in the Clinton administration.

Curtis Van Tassell, a geneticist at the United States Agricultural Research Service's Bovine Functional Genomics Laboratory in Beltsville, Md., has been awarded a Herbert L. Rothbart Outstanding Early Career Research Scientist of theYear award from ARS, the agency said last week.

Ben Bronstein, managing director at Zero Stage Capital, joins the board of directors of BioTrove of Woburn, Mass. Previously, he served as interim CEO for Spherics; co-founder, president and CEO of Peptimmune; and vice president of medical affairs and medical director of BioSurface Technology, which was acquired by Genzyme shortly after its initial public offering. Bronstein holds an AB in biology (magna cum laude), an MD and an MBA (with high honors), from Boston University.

Peter Johnson will become executive vice president and chief medical officer of Paradigm Genetics upon the closing of its acquisition of Pittsburgh, Pa.-based TissueInformatics in an $8 million deal announced last week. Johnson is the chairman and CEO of TissueInformatics, which sells tissue pathology software and services. Other members of the TissueInformatics management team joining Paradigm include: Mark Braughler, senior vice president of business development, who will become vice president for healthcare business development; Todd Joron, senior vice president, who will become head of TissueAnalytics software; and Max Fedor, vice president for product development, who will head product development.


The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.